Unique Cutaneous Reaction to Second- and Third-Generation Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia

Publisher： Karger

E-ISSN： 1421-9832|232|1|122-125

ISSN： 1018-8665

Source： Dermatology, Vol.232, Iss.1, 2016-0, pp. : 122-125

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intensified Inflammatory Reaction of Actinic Keratoses after Single Application of Topical 5-Fluorouracil in a Patient Treated with Nilotinib for Chronic Myeloid Leukemia

By  

Dermatology, Vol. 219, Iss. 4, 2009-05 ,pp. : 341-343

Karger

Access to resources Recommend Favorite

Severe Pustular Eruption Associated with Imatinib and Voriconazole in a Patient with Chronic Myeloid Leukemia

By  

Dermatology, Vol. 211, Iss. 4, 2005-12 ,pp. : 363-365

Karger

Access to resources Recommend Favorite

Acute Generalized Exanthematous Pustulosis Associated with STI571 in a Patient with Chronic Myeloid Leukemia

By  

Dermatology, Vol. 203, Iss. 1, 2001-09 ,pp. : 57-59

Karger

Access to resources Recommend Favorite

Unusual Manifestation of Specific Cutaneous Involvement by B-Cell Chronic Lymphocytic Leukemia: Spontaneous Regression with Scar Formation

By  

Dermatology, Vol. 207, Iss. 1, 2003-07 ,pp. : 111-115

Karger

Access to resources Recommend Favorite

Genital Infection as a First Sign of Acute Myeloid Leukemia

By  

Case Reports in Dermatology, Vol. 2, Iss. 1, 2010-02 ,pp. : 18-21

Karger

Access to resources Recommend Favorite